abstract |
The present invention relates to gastrin-releasing peptide receptors (GRPRs) targeting radiopharmaceuticals and uses thereof. In particular, the present disclosure relates to a pharmaceutical composition comprising a radiolabeled GRPR-antagonist and a surfactant. The present disclosure also relates to radiolabeled GRPR-antagonists for use in treating or preventing cancer. |